Skip to main content
Journal of Assisted Reproduction and Genetics logoLink to Journal of Assisted Reproduction and Genetics
. 2001 Nov;18(11):608–611. doi: 10.1023/A:1013165006406

Improved Responsiveness of PCOS Patients to Clomiphene After CYP17a Inhibitor

Hassan Ali Hassan 1,2, Dalal El-Gezeiry 1,3, Tamer M Nafaa 1, Iman Baghdady 2
PMCID: PMC3455693  PMID: 11804430

Abstract

Purpose: To study the effect of CYP17a inhibitor, “ketoconazole,” on clomiphene responsiveness in PCOS patients.

Methods: Prospective analysis was employed with the setup at Alexandria IVF/ICSI center. Ninety-seven insulin-resistant PCOS patients undergoing ovulation induction using clomiphene citrate were randomly divided, by random number table, into two groups. The first group (n = 49) received ketoconazole (400 mg daily) till correction of metabolic syndrome followed by clomiphene (100 mg/day); the second group (n = 48) receiving clomiphene without ketoconazole pretreatment. Main outcome measures were incidence of clomiphene resistance, monofollicular response, fasting insulin/glucose ratio, serum testosterone, and pregnancy rates.

Results: The ketoconazole group showed significantly (p < 0.05) higher incidence of monofollicular response (38%), higher pregnancy rates, and significantly less marked antiestrogenic manifestations than did the control group. They also had significantly lower incidence of clomiphene resistance (11.6%), lower serum testosterone levels, less hyperinsulinaemia, than did the control group.

Conclusion: Ketoconazole improved clomiphene responsivenss in PCOS patients and attenuated its untoward biological effects.

Keywords: clomiphene resistance, CYP17a inhibitor, hyperandrogenism, insulin resistance, ketoconazole, PCOS

Full Text

The Full Text of this article is available as a PDF (52.7 KB).

REFERENCES

  • 1.Zhang L, Rodriguez H, Ohno S, Miller WL. Serine phosphorylation of human P450c17 increases 17,20 lyase activity: Implications for adrenarche and polycystic ovarian syndromre. Proct Natl Acad Sci USA. 1995;92:10619. doi: 10.1073/pnas.92.23.10619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Imani B, Eijekmans MJC, te Velde ER, Habbema JDF, Fauser BCJM. Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotrophic oligomenorrhoeic infertility. J Clin Endocrinol Metab. 1998;83:2361. doi: 10.1210/jcem.83.7.4919. [DOI] [PubMed] [Google Scholar]
  • 3.Agrawal SK, Judd HL, Magoffin DA. A mechanism for the supression of estrogen production in PCOS. J Clin Endocrinol Metab. 1996;81:3686. doi: 10.1210/jcem.81.10.8855823. [DOI] [PubMed] [Google Scholar]
  • 4.Jakimiuk AJ, Weitsman SR, Magoffin DA. 5-alpha reductase activity in women with PCOS. J Clin Endocrinol Metab. 1999;84(7):2414–2418. doi: 10.1210/jcem.84.7.5863. [DOI] [PubMed] [Google Scholar]
  • 5.Anderson E, Lee GY. The effects of DHEA and its metabolites on the PCO condition: Cystogenic changes of rat granulosa cells in vitro. Tissue Cell. 1996;28(6):673–685. doi: 10.1016/s0040-8166(96)80071-1. [DOI] [PubMed] [Google Scholar]
  • 6.Wiilis DS, Watson H, Mason HD, Galea R, Brincat M, Franks S. Premature response to LH of granulosa cells from anovulatory women with PCOS: Relevance to mechanism of ovulation. J Clin Endocrinol Metab. 1998;83(11):3984–3991. doi: 10.1210/jcem.83.11.5232. [DOI] [PubMed] [Google Scholar]
  • 7.Fauser BC. Observations in favor of normal early follicular development and disturbed dominant follicle selection in PCOS. Gynecol Endocrinol. 1994;8:75. doi: 10.3109/09513599409058026. [DOI] [PubMed] [Google Scholar]
  • 8.Ciaraldi TP, Elroeiy A, Madar Z, Reichart D, Olefsky JM, Yen SCC. Cellular mechanisms of insulin resistance in PCOS. J Clin Endocrinol Metab. 1992;75:577. doi: 10.1210/jcem.75.2.1322430. [DOI] [PubMed] [Google Scholar]
  • 9.Dunaif A, Xia J, Book C-B, Schenker E, Tang Z. Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle: A potential mechanism for insulin resistance in PCOS. J Clin Invest. 1995;96:801. doi: 10.1172/JCI118126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Fradkin JE, Eastman RC, Lesnik MA, Roth J: Specificity spillover at the hormone receptor: Exploring its role in human disease, New Engl J Med 1989;320-640 [DOI] [PubMed]
  • 11.Yoshimura Y, Nakamura Y, Koyama N, Iwashita M, Adachi T, Takeda Y. Effects of growth hormone on follicle growth, oocyte maturation, and ovarian steoidogenesis. Fertil Steril. 1993;59(4):917–923. doi: 10.1016/s0015-0282(16)55882-8. [DOI] [PubMed] [Google Scholar]
  • 12.Manson HD, Wiilis DS, Beard RW, Winston RML, Margara R, Franks S. Estradiol production by granulosa cells of normal and polycystic ovaries: Relationship to menstrual cycle history and concentrations of sex steroids in follicular fluid. J Clin Endocrinol Metab. 1994;79:1355. doi: 10.1210/jcem.79.5.7962330. [DOI] [PubMed] [Google Scholar]
  • 13.Almahbobi G, Anderiesz C, Hutchison P, McFarlane JR, Wood C, Trounson AO. Functional integrity of granulosa cells from polycystic ovaries. Clin Endocrinol. 1996;44:571. doi: 10.1046/j.1365-2265.1996.724545.x. [DOI] [PubMed] [Google Scholar]
  • 14.Nestler JE, Powers LP, Matt DW, Steingold KA, Plymate SR, Rittmaster RS, Clore JN, Blackard WG. A direct effect of hyperinsulinaaemia on serum SHBG levels in obese women with PCOS. J Clin Endocrinol Metab. 1991;72:38. doi: 10.1210/jcem-72-1-83. [DOI] [PubMed] [Google Scholar]
  • 15.Cataldo NA, Gludice LC. Follicular fluid IGFBP profiles in PCOS. J Clin Endocrinol Metab. 1992;74:695. doi: 10.1210/jcem.74.3.1371292. [DOI] [PubMed] [Google Scholar]
  • 16.San Roman GA, Magoffin DA. IGFBP in ovarian follicles from women with PCOS: Cellular sources and levels in follicular fluid. J Clin Endocrinol Metab. 1992;75:1010. doi: 10.1210/jcem.75.4.1383254. [DOI] [PubMed] [Google Scholar]
  • 17.Bergh C, Carlsson B, Olsson J-H, Selleskog U, Hillenjso T. Regulation of androgen production in cultured human theca cells by IGF-1 and insulin. Fertil Steril. 1993;59:323. doi: 10.1016/s0015-0282(16)55675-1. [DOI] [PubMed] [Google Scholar]
  • 18.Pont A, Williams PL, Loose DS, Feldman D, Reitz RE, Bochra C, Stevens DA. Ketoconazole blocks adrenal steroid synthesis. Ann Intern Med. 1982;97(3):370–372. doi: 10.7326/0003-4819-97-3-370. [DOI] [PubMed] [Google Scholar]
  • 19.Santen RJ, van den Bossche H, Symoens J, De Coster R. S. ite of action of low dose ketoconazole on androgen biosynthesis in men. J Clin Endocrinol Metab. 1983;57(4):732–736. doi: 10.1210/jcem-57-4-732. [DOI] [PubMed] [Google Scholar]
  • 20.DeCoster R, Mahler C, Denis L, Coene MC, Caers I, Amery W, et al. Effects of high dose ketoconazole and dexamethazone on ACTH-stimulated adrenal steroidogenesis in orchiectomized prostatic cancer patients. Acta Endocrinol (Copenh) 1987;115(2):265–271. doi: 10.1530/acta.0.1150265. [DOI] [PubMed] [Google Scholar]
  • 21.Gerace L. Molecular trafficking across the nuclear pore complex. Curr Opin Cell Biol. 1992;4:637. doi: 10.1016/0955-0674(92)90083-o. [DOI] [PubMed] [Google Scholar]
  • 22.Sasson S, Notides AC. The inhibition of ER positive cooperative [3H] estradiol binding by the antagonist clomiphene. J Biol Chem. 1982;257:11540. [PubMed] [Google Scholar]
  • 23.Eisenfeld AJ, Axelrod J: Evidence for estradiol binding sites in the hypothalamus-Effects of drugs. Biochem Pharmacol 1967;16-1781 [DOI] [PubMed]
  • 24.Gal M, Orly J, Barr I, Algir N, Nolds R, Diamant YZ. Low dose ketoconazole attenuates serum androgen levels in patients with PCOS and inhibits ovarian steroidogenesis in vitro. Fertil Steril. 1994;61(5):823–832. doi: 10.1016/s0015-0282(16)56691-6. [DOI] [PubMed] [Google Scholar]
  • 25.Chang RJ, Mandel FP, Lu JK, Judd HL. Enhanced disparity of gonadotrophin secretion by estrone in women with PCOS. J Clin Endocrinol Metab. 1982;54:490. doi: 10.1210/jcem-54-3-490. [DOI] [PubMed] [Google Scholar]
  • 26.Rosener W. The functions of corticosteroid binding globulin and sex hormone-binding globulin: Recent advances. Endocrin Rev. 1990;11:80. doi: 10.1210/edrv-11-1-80. [DOI] [PubMed] [Google Scholar]
  • 27.Evans NP, Dahl GE, Clay CM, Nett TM. Regulation of GnRH receptor mRNA and GnRH during early preovulatory period in the ewe. Endocrinology. 1994;135:1353–1358. doi: 10.1210/endo.135.4.7925096. [DOI] [PubMed] [Google Scholar]
  • 28.Chappel SC, Resko JA, Norman RL, Spies HG. Studies on Rhesus monkeys on the site where estrogen inhibits gonadotrophins: Delivery of 17 B estradiol to the hypothalamus and gland. J Clin Endocrinol Metab. 1981;2:1. doi: 10.1210/jcem-52-1-1. [DOI] [PubMed] [Google Scholar]
  • 29.Manson M, Fonseca E, Ruiz JE, Moran C, Zarate A. Distribution of FSH and LH isoforms in sera from women with primary ovarian failure compared with that of normal reproductive and postmenopausal women. Fertil Steril. 1992;58:60. doi: 10.1016/s0015-0282(16)55137-1. [DOI] [PubMed] [Google Scholar]
  • 30.Hung TT, Gibbons WE. Evaluation of androgen antagonism to estrogen by dihydroestosterone. J Steroid Biochem. 1983;19:1513. doi: 10.1016/0022-4731(83)91128-7. [DOI] [PubMed] [Google Scholar]
  • 31.Kesel B, Liu YX, Jia XC, Hseuh AJW. Autocrine role of estrogens in the augmentation of LH receptor formati, in cultured rat granulosa cells. Biol Reprod. 1985;32:1038. doi: 10.1095/biolreprod32.5.1038. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Assisted Reproduction and Genetics are provided here courtesy of Springer Science+Business Media, LLC

RESOURCES